Lenka Hernychova is an expert in Biochemistry at Masaryk Memorial Cancer Institute (Czechia). Lenka Hernychova has authored 91 publications, the most recent in 2026. SLR score: 220 (community average: 125). How the SLR is computed.

LeadR Profile

Lenka Hernychova Masaryk Memorial Cancer Institute Czechia
220 ScienceLeadR Reputation 220
Network Map

Biochemistry

Subspecialties: Genetics - Oncology - Immunology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2012 - 2026

Source: PubMed

Masaryk Memorial Cancer Institute

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 91

Citations

Citations: 1 428 1st author: 6 Last author: 10 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Post-Search Validation and Curation of Site-Resolved N‑Glycoproteomics Data.
PMID 42819908 — serum, workflow, glycopeptides
JACS Au20260
HPV infection and its significance in the development and prevention of cervical cancer.
PMID 42663153 — early diagnosis, vaccines, uterine cervical neoplasms, neoplasms, vaccination, diagnosis, alphapapillomavirus, papillomavirus infections, infections, human papillomavirus viruses
Klin Onkol20260
MDM2 suppresses c-Myc synthesis by binding to the 5' mRNA translation regulatory sequence.
PMID 42335241 — genes, myc, pharmaceutical preparations, neoplasms, rna, messenger, genes, p53, therapeutics, protein biosynthesis
Proc Natl Acad Sci U S A20260
Taurine inhibits apolipoprotein E4 aggregation.
PMID 42066671 — apolipoprotein e4, protein isoforms, drug therapy, research, apolipoproteins, taurine
Biomed Pharmacother20260
GPA33 forms a distinct diagnostic target class to Claudin 18.2 in oesophageal adenocarcinoma enabling the development of a novel GPA33 antibody-based detection platform.
PMID 41808009 — cells, physiology, epitopes, antibodies, molecular biology, neoplasms, adenocarcinoma, enzyme-linked immunosorbent assay, bacteriophages, antibodies, monoclonal, therapeutics, tissues, claudins
Cell Mol Biol Lett20260

LeadR Networks

Main global connection map